Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and Lamivudine can be successfully treated with a quadruple-nucleoside regi (Q46844814)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and Lamivudine can be successfully treated with a quadruple-nucleoside regi |
scientific article |
Statements
1 reference
Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and Lamivudine can be successfully treated with a quadruple-nucleoside regi (English)
1 reference
Allan Rodriguez
1 reference
Christina Hill-Zabala
1 reference
Louis Sloan
1 reference
Thomas Jefferson
1 reference
Linda Yau
1 reference
Maria Watson
1 reference
David Irlbeck
1 reference
Mark Shaefer
1 reference
1 January 2006
1 reference
41
1 reference
1
1 reference
127-129
1 reference